Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on April 15, 2025

BrandQuantum Blooms with G2 Spring 2025 Awards
BrandQuantum, a leader in brand consistency solutions, announces its 17th celebration as BrandMail and BrandOffice shine in the G2 Spring 2025 Awards. WICHITA, KS, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Just as spring marks fresh growth, …

equalyzAI Launches Groundbreaking Technology to Bridge Global AI Divide
Revolutionary African-Centric AI Platform Creates First-Ever Models that Truly Understand and Process African Languages and Contexts LAGOS, NIGERIA, April 15, 2025 /EINPresswire.com/ -- equalyzAI, a pioneering African-centric AI startup, unveiled its …

A Story of Survival, A Message of Hope: Mother Pens Memoir After Son’s Triumph Over Rare Heart Condition
‘HEARTBEAT OF HOPE’ – A MEMOIR OF FAITH, FIGHT, AND A MOTHER’S UNBREAKABLE LOVE Explores the Depth of Maternal Strength and the Power of Hope Against All Odds LONDON, LONDON, UNITED KINGDOM, April 15, 2025 /EINPresswire.com/ -- When the heart of a …

Kinshasa Hosts 16th AfCFTA Ministerial: Africa Deepens Economic Integration as DRC Strengthens Its Business Climate
His Excellency Julien Paluku Kahongya chairs the 16th AfCFTA Ministerial Conference. KINSHASA, CONGO-KINSHASA, April 15, 2025 /EINPresswire.com/ -- The Democratic Republic of Congo (DRC) is proudly hosting the 16th Meeting of Foreign Trade Ministers …

Source Energy Services Announces Upcoming Earnings Release
CALGARY, Alberta, April 15, 2025 (GLOBE NEWSWIRE) -- TSX:SHLE FIRST QUARTER RESULTS RELEASE AND CONFERENCE CALL Source is pleased to announce that its first quarter financial results for the period ending March 31, 2025, will be released following the …

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …

Wingu Africa Appoints Ralph Vraagom as Vice President, Sales
Ralph Vraagom was announced as Wingu Group's VP of sales on 1 April 2025, bringing 20+ years of ICT leadership to drive growth and boost commercial excellence. JOHANNESBURG, GAUTENG, SOUTH AFRICA, April 15, 2025 /EINPresswire.com/ -- Wingu Africa …

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

Koryx Copper Announces Change of Auditor
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (“Koryx” or the "Company") (TSX-V: KRY) (NSX: KYX) announces that it has changed its auditor from Crowe MacKay LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”) …

Canadian North Resources Inc. Reports Operational and Financial Results for the Year Ended December 31, 2024
2024 Operational and Project Highlights: Completed and filed the new National Instrument 43-101 Technical Report that defines the large and high-grade Mineral Resources at the 100% owned Ferguson Lake Project (Table 1). 80% of the Indicated Mineral …

Verde Announces Court Approval of Debt Renegotiation Agreement
The Agreement Secures Extended Payment Terms and Reduced Interest Rates, Enhancing Liquidity SINGAPORE, April 15, 2025 (GLOBE NEWSWIRE) -- Verde Agritech Ltd (TSX: “NPK”) ("Verde” or the “Company”) is pleased to announce that the civil court has …

Robex Announces Entry into Underwriting Agreement
Not for release to US wire services or distribution in the United States QUÉBEC CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company”) is pleased to announce that it has entered into an underwriting agreement ( …

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has signed a …

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or refractory large B-cell lymphoma. RMAT designation recognizes the potential of LYL314 to address significant unmet …

Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Charlotte Moser, MD, PhD …

ESGold Corp. Issues Corporate Update as It Advances Toward Production and Expanded Exploration at Montauban
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- via IBN - ESGold Corp. (“ESGold” or the “Company”) (CSE: ESAU | OTCQB: ESAUF | FSE: Z7D) Canada’s next gold and silver producer, is pleased to provide a corporate update outlining recent …

Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …

Lisata Therapeutics Announces Research License with Catalent
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …